Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis

It is urgent to find an optimised therapy regimen for the control of MDR-TB globally. This study aimed to evaluate the efficiacy and safety of a combined regimen of rhIL-2 injection and standard chemotherapy within 18-month duration in a randomized controlled trial conducted in 14 centres in eastern...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Qi, Min, Rui, Dai, Guan-qun, Wang, Yan-li, Nan, Li, Yang, Zhen, Xia, Jun, Pan, Shi-yang, Mao, Huang, Xie, Wei-ping, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736576/
https://www.ncbi.nlm.nih.gov/pubmed/29259310
http://dx.doi.org/10.1038/s41598-017-18200-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736576/
https://www.ncbi.nlm.nih.gov/pubmed/29259310
http://dx.doi.org/10.1038/s41598-017-18200-5

Ejemplares similares